Skip to main content
. 2016 Sep 2;107(10):1430–1442. doi: 10.1111/cas.13018

Figure 1.

Figure 1

Association of high expression of podocalyxin‐like protein (PODXL) with poor outcome in patients with pancreatic ductal adenocarcinoma (PDAC). (a) Immunohistochemical staining of PDAC tissues using anti‐PODXL antibody. PODXL staining was present in the cytoplasm of tumor cells. Magnification, ×200. (b) Immunohistochemical staining of PDAC tissues using anti‐PODXL antibody. Membrane staining of PODXL was observed in tumor cells. Magnification, ×200. (c,d) Kaplan–Meier analysis of PDAC‐specific survival (c) and overall survival (d) according to PODXL expression.